Modulating the lipid profile of blastocyst cell membrane with DPPC multilamellar vesicles.

Artificial cells, nanomedicine, and biotechnology 2022 Dec

filter terms:

The aim of this study was to evaluate the effect of multilamellar vesicles (MLVs) of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) in co-culture with in vitro-produced bovine embryos (IVPEs). The stability of five concentrations of MLVs (1.0, 1.25, 1.5, 1.75, and 2.0 mM) produced using ultrapure water or embryonic culture medium with 24 or 48 h of incubation at 38.5 °C with 5% CO2 was assessed. In addition, the toxicity of MLVs and their modulation of the lipid profile of the plasma membrane of IVPEs were evaluated after 48 h of co-culture. Both media allowed the production of MLVs. Incubation (24 and 48 h) did not impair the MLV structure but affected the average diameter. The rate of blastocyst production was not reduced, demonstrating the nontoxicity of the MLVs even at 2.0 mmol/L. The lipid profile of the embryos was different depending on the MLV concentration. In comparison with control embryos, embryos cultured with MLVs at 2.0 mmol/L had a higher relative abundance of six lipid ions (m/z 720.6, 754.9, 759.0, 779.1, 781.2, and 797.3). This study sheds light on a new culture system in which the MLV concentration could change the lipid profile of the embryonic cell membrane in a dose-dependent manner.

Citation

Hugo De Rossi, Camila Bortoliero Costa, Luana Teixeira Rodrigues-Rossi, Giovana Barros Nunes, Dóris Spinosa Chéles, Isabella Maran Pereira, Daniele F O Rocha, Eloi Feitosa, Ana Valéria Colnaghi Simionato, Gisele Zoccal Mingoti, Pedro Henrique Benites Aoki, Marcelo Fábio Gouveia Nogueira. Modulating the lipid profile of blastocyst cell membrane with DPPC multilamellar vesicles. Artificial cells, nanomedicine, and biotechnology. 2022 Dec;50(1):158-167